Pacer Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Pacer Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,328	Closed	-$554K	–	2372
2022 Q4	$554K	Buy	12,328 +5,062	+70%	+$229K	﹤0.01%	1179
2022 Q3	$348K	Buy	+7,266	New	+$398K	﹤0.01%	1107
2022 Q2	–	Sell	-1,483	Closed	-$172K	–	2439
2022 Q1	$172K	Sell	1,483 -7,551	-84%	-$882K	﹤0.01%	2160
2021 Q4	$1.36M	Buy	9,034 +4,493	+99%	+$606K	0.01%	1022
2021 Q3	$542K	Buy	+4,541	New	+$500K	0.01%	1109

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pacer Advisors's TNDM Position: Q1 2023 in Review

Pacer Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 12,328 shares — an estimated $554K sold.

Pacer Advisors first reported a position in TNDM in Q3 2021 and held it in 5 quarters. The position peaked at $1.36M in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

Pacer Advisors reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
Pacer Advisors sold 12,328 Tandem Diabetes Care shares in Q1 2023, an estimated $554K.
Pacer Advisors first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 5 quarters.
Pacer Advisors's Tandem Diabetes Care position peaked at $1.36M in Q4 2021.
273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Pacer Advisors's 13F filing for Q1 2023, filed 2 May 2023.